Cambridge Investment Research Advisors’s TG Therapeutics TGTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-7,182	Closed	-$279K	–	3203
2021 Q2	$279K	Sell	7,182 -11,497	-62%	-$447K	﹤0.01%	2526
2021 Q1	$900K	Buy	18,679 +453	+2%	+$21.8K	﹤0.01%	1503
2020 Q4	$948K	Buy	18,226 +247	+1%	+$12.8K	0.01%	1341
2020 Q3	$481K	Buy	+17,979	New	+$481K	﹤0.01%	1625